Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp260 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

Dietary phosphorus intake is positively associated with some radial and tibial pQCT bone traits in premenopausal females with seemingly high calcium intake

Itkonen Suvi , Saarnio Elisa , Kemi Virpi , Karp Heini , Pekkinen Minna , Rita Hannu , Sievanen Harri , Laitinen Kalevi , Lamberg-Allardt Christel

Phosphorus intake in western countries is high due to abundant consumption of animal protein and also because of the expanding use of highly absorbable food additive phosphate (FAP) salts in food processing. P is essential for hydroxyapatite in bone, but short-term studies have shown that high P, especially FAP, intake has acute negative effects on bone metabolism. In this study, we investigated the associations between dietary P intake and bone turnover markers by using a cro...

ba0003pp306 | Osteoporosis: treatment | ECTS2014

The effect of bisphosphonate treatment on sclerostin levels in postmenopausal osteoporosis: the TRIO study

Gossiel Fatma , Naylor Kim , McCloskey Eugene , Peel Nicola , Walsh Jennifer , Paggiosi Margaret , Eastell Richard

Treatment of postmenopausal osteoporosis with bisphosphonates reduces bone resorption and formation. Sclerostin, an osteocyte regulator of bone formation may be involved in these changes. Some studies have reported an increase in sclerostin associated with bisphosphonate treatment while others have reported a decrease. The aims were to determine the effect of bisphosphonates on i) circulating sclerostin and ii) PINP in postmenopausal women with osteoporosis. We studied 92 post...

ba0003pp343 | Osteoporosis: treatment | ECTS2014

Clinical experience with Denosumab in the treatment of osteoporosis

Hoo Teng , Berg Jackie , Langlands Alison , Riches Philip , Ralston Stuart

Background: Denosumab is licensed for the treatment of osteoporosis in the UK. Guidance issued by NICE and SMC in indicated that Denosumab may be used in the treatment of patients with postmenopausal osteoporosis who are unsuitable for other treatments. Here we have reviewed the clinical characteristics of patients treated within a secondary care referral centre adverse events encountered during treatment.Methods: We reviewed data from 75 consecutive pat...

ba0003pp359 | Osteoporosis: treatment | ECTS2014

Ten year alendronate use does not adversely affect bone quality compared to 5 years use: a human iliac crest biopsy study

Hassler Norbert , Gamsjaeger Sonja , Hofstetter Birgit , Brozek Wolfgang , Misof Barbara , Roschger Paul , Klaushofer Klaus , Paschalis Eleftherios

Bisphosphonates (BPs) including alendronate (ALN) are the most widely prescribed therapy for post-menopausal osteoporosis. Despite their overall excellent safety record and efficacy in reducing fractures, concerns have been expressed lately regarding potential detrimental effects due to prolonged bone turnover reduction, although no definite cause–effect relationship has been established to date. The purpose of the present study was to determine bone material quality by R...

ba0003pp381 | Other diseases of bone and mineral metabolism | ECTS2014

The influence of black and white tea on bone development of rat exposured to cadmium and lead

Dobrowolski Piotr , Tomaszewska Ewa , Winiarska-Mieczan Anna , Kwiecien Malgorzata , Prost Lukasz , Burmanczuk Natalia , Kurlak Paulina

Tea is the second most consumed beverage in the world, next to water. The popularity of tea is determined by healthy properties connected with the presence of antioxidants, hence tea can be classified as functional food. Cadmium (Cd) and lead (Pb) are toxic metals commonly occurring in the human environment with exposure ~5 and 35 mg/kg Bw per week respectively.Thirty growing male Wistar rats (12 weeks old, 326.4±31.0 g) were used. Rat were fed ...

ba0004op11 | (1) | ICCBH2015

Optimal dose of calcium for treatment of nutritional rickets

Thacher Tom , Smith Lauren , Fischer Philip , Cha Stephen , Isichei Christian , Pettifor John

Objective: Nutritional rickets in Nigerian children is primarily due to dietary calcium deficiency and heals with calcium supplementation. Our aim was to determine the optimal dose of calcium for treatment of children with rickets due to dietary calcium deficiency.Methods: At the Jos University Teaching Hospital, 65 Nigerian children with radiographically-confirmed rickets were randomized to daily supplemental calcium intake of 500 mg (n=21), 10...

ba0004p62 | (1) | ICCBH2015

Association of dental and skeletal fluorosis with calcium intake and vitamin D concentrations in adolescents from a region endemic for fluorosis

Kajale Neha , Patel Prerna , Patel Pinal , Patel Ashish , Yagnik Bhrugu , Mandlik Rubina , Patwardhan Vivek , Khadilkar Vaman , Chiplonkar Shashi , Mughal Zulf , Joshi Priscilla , Phanse-Gupte Supriya , Khadilkar Anuradha

Objective: Patan, is a semi urban area in Gujarat, India where fluorosis is endemic (Fluoride concentration in ground water 1.96–10.85 ppm, Patel et al., 2008). Exposure to fluoride is likely to be higher in lower socio-economic class (SEC) due to lack of access to bottled water. Calcium intake and vitamin D status may modify fluorine absorption. Therefore, the aims of this study were to examine: i) prevalence of dental and skeletal fluorosis in children from upper, middl...

ba0005p382 | Osteoporosis: treatment | ECTS2016

Effects of single bolus injection of vitamin D on serum FGF23, Sclerostin and DKK1 concentrations in vitamin D-deficient subjects

Dong Jang Dong , Choi Hoon , Lim Sung-Kil

Objective: Bone is one of endocrine organ and osteocytes secretes FGF23, Sclerostin and DKK1. FGF23 inhibits renal phosphate reabsorption and suppresses 1-α hydroxylase activity. Calcitriol stimulates FGF23 synthesis in bone. We aimed to determine the effect of single bolus injection of vitamin D on serum FGF23, DKK1 and Sclerostin concentrations in vitamin D-deficient subjects.Design and methods: The study group was composed of placebo group with s...

ba0005p410 | Osteoporosis: treatment | ECTS2016

Can bone turnover markers help to define the duration of bisphosphonate drug holidays?

Statham Louise , Aspray Terry , Abdy Sharon

Background: On cessation of bisphosphonate treatment, while bone mineral density decreases slowly, bone resorptive markers such as C-terminal telopeptide (CTX) increase more quickly and may be useful in monitoring ‘offset’ of action. Our aim was to analyse changes in CTX on stopping long-term bisphosphonate treatment to guide clinical decision-making on the duration of treatment cessation (‘drug holidays’).Subjects and methods: A tota...

ba0005p454 | Other diseases of bone and mineral metabolism | ECTS2016

Bone mineral density and vascular calcification in obesity

Bouquegneau Antoine , Walsh Jennifer , Evans Amy , Paggiosi Margaret , Eastell Richard

Background: The presence of vascular calcification (VC) is a predictive factor for the development of cardiovascular diseases, especially in the obese population. VC has also been inversely associated with bone mineral density (BMD) but the results have been inconsistent. The main aim of this study was to evaluate the associations between VC, obesity and volumetric BMD (vBMD).Methods: We studied 148 healthy men and women, aged 55–75 years, divided i...